(Q45789818)

16 December 2017

title

THF gamma 2 stimulates cytokine release by peripheral blood mononuclear cells of patients with chronic hepatitis B virus infection (English)

1 reference

16 December 2017

1 reference

1 reference

Daniels HM

1

1 reference

16 December 2017

O'Toole A

2

1 reference

16 December 2017

Hussein MJ

3

1 reference

16 December 2017

Corridori S

4

1 reference

16 December 2017

Alexander GJ

5

1 reference

16 December 2017

Williams R

6

1 reference

16 December 2017

publication date

1 March 1994

1 reference

16 December 2017

published in

Journal of Hepatology

1 reference

16 December 2017

volume

20

1 reference

16 December 2017

issue

3

1 reference

16 December 2017

page(s)

370-375

1 reference

16 December 2017

Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Functional analysis of peripheral blood lymphocytes isolated from patients with chronic hepatitis type B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

The Liver Histology and Frequency of Clearance of the Hepatitis B Surface Antigen (HBsAg) in Chronic Carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

In vitro alpha-interferon treatment of peripheral blood mononuclear cells improves interleukin-2 activity in HBV-related chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Differential effect of alpha-interferons on CD4- and CD8-positive lymphocytes in chronic hepatitis B virus carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

In vitro effect of TP-1 (a calf thymic extract) on suppressor T-cell function of patients with autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

A comparative study on the immunological effects of bovine and porcine thymic extracts: induction of lymphoproliferative response and enhancement of interleukin-2, gamma-interferon and tumor necrotic factor production in vitro on cord blood lymphocy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Thymic humoral factor gamma 2: purification and amino acid sequence of an immunoregulatory peptide from calf thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Effect of Thymic Humoral Factor on Cellular Immune Functions of Normal Children and of Pediatric Patients with Ataxia Telangiectasia and Down's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Biochemical and biological properties of THF in animal and human models

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Quantitation of hepatitis B virus DNA (HBV DNA) in serum using the spot hybridization technique and scintillation counting

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Increased reactivity of mouse spleen cells sensitized in vitro against syngeneic tumor cells in the presence of a thymic humoral factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Antiviral effects of recombinant tumour necrosis factor in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2894%2980010-3

7 January 2021

10.1016/S0168-8278(94)80010-3

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017